A novel class of lipophilic quinazoline-based folic acid analogues: cytotoxic agents with a folate-independent locus.

作者: L A Skelton , M G Ormerod , J Titley , R Kimbell , L A Brunton

DOI: 10.1038/SJ.BJC.6690270

关键词:

摘要: Three lipophilic quinazoline-based aminomethyl pyridine compounds, which differ only in the position of nitrogen their ring, are described. CB300179 (2-pyridine), CB300189 (4-pyridine) and CB30865 (3-pyridine) all inhibited isolated mammalian TS with IC50 values 508, 250 156 nM respectively. was most potent growth inhibitory agent (IC50 range 1– 100 for several mouse human cell types). were active micromolar range. Against W1L2 cells, demonstrated reduced potency presence exogenous thymidine (dThd), against a W1L2:C1 overproducing line. In contrast, retained activity these systems. Furthermore, combinations precursors end products folate metabolism, e.g. dThd/hypoxanthine (HX) or leucovorin (LV), did not prevent activity. interfere incorporation tritiated dThd, uridine leucine after 4 h. A line raised acquired resistance to (W1L2:R865; > 200-fold), cross-resistant CB300189. addition, W1L2:R865 cells as sensitive parental agents from major chemotherapeutic drug classes. induced an S phase accumulation (preventable by co-administration dThd). No cycle redistribution observed following exposure (4–48 h) equitoxic concentration CB30865. NCI anticancer drug-discovery screen, displayed pattern consistent known anti-tumour agents. These data suggest that represents class potential novel mechanism action.

参考文章(23)
M. R. Boyd, K. D. Paull, L. R. Rubinstein, Data Display and Analysis Strategies for the NCI Disease-Oriented in Vitro Antitumor Drug Screen Springer, Boston, MA. pp. 11- 34 ,(1992) , 10.1007/978-1-4615-3492-1_2
T. C. Stephens, M. N. Smith, S. E. Waterman, M. L. McCloskey, A. L. Jackman, F. T. Boyle, Use of Murine L5178Y Lymphoma Thymidine Kinase Mutants for in Vitro and in Vivo Antitumour Efficacy Evaluation of Novel Thymidylate Synthase Inhibitors Advances in Experimental Medicine and Biology. ,vol. 338, pp. 589- 592 ,(1993) , 10.1007/978-1-4615-2960-6_120
Aurelio Lorico, Giuseppe Toffoli, Mauro Boiocchi, Eugenio Erba, Massimo Broggini, Germana Rappa, Maurizio D'Incalci, Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5,8-dideazafolic acid. Cancer Research. ,vol. 48, pp. 2036- 2041 ,(1988)
Ann L. Jackman, Sarah E. Freemantle, John Lunec, Philip H. Crossley, Brigid M. O'Connor, A. Hilary Calvert, Human lymphoblastoid cells with acquired resistance to C2-desamino-C2-methyl-N10-propargyl-5,8-dideazafolic acid: a novel folate-based thymidylate synthase inhibitor. Cancer Research. ,vol. 52, pp. 1137- 1143 ,(1992)
G Jansen, L Brunton, R Kimbell, A L Jackman, J M Wardleworth, M N Smith, G W Aherne, F T Boyle, T C Stephens, Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase. Clinical Cancer Research. ,vol. 3, pp. 911- 921 ,(1997)
FT Boyle, AL Jackman, LR Kelland, R Kimbell, M Brown, W Gibson, GW Aherne, A Hardcastle, Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines British Journal of Cancer. ,vol. 71, pp. 914- 924 ,(1995) , 10.1038/BJC.1995.178
J. Y. Charcosset, Effects of antineoplastic agents on the cell cycle progression Biology of the Cell. ,vol. 58, pp. 135- 138 ,(1986) , 10.1111/J.1768-322X.1986.TB00497.X
PR Twentyman, M Luscombe, A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. British Journal of Cancer. ,vol. 56, pp. 279- 285 ,(1987) , 10.1038/BJC.1987.190